Lanean...
Immunotherapy treatments for small-cell lung cancer: past, present and future
Small-cell lung cancer remains a considerable cause of morbidity and mortality. To this day, first-line therapy continues to be a platinum agent with etoposide, combined with radiation therapy in cases of limited stage disease. Numerous, largely unsuccessful, attempts at controlling the disease have...
Gorde:
| Argitaratua izan da: | Lung Cancer Manag |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4520540/ https://ncbi.nlm.nih.gov/pubmed/26236401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/lmt.13.62 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|